$MDT

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.

Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.

Global personalized nutrition market projected to grow from $15.79B in 2025 to $30.94B by 2030 at 14.4% CAGR, with Asia Pacific driving expansion.

Intuitive Surgical and DexCom positioned for long-term growth despite near-term competition, driven by aging populations and untapped market opportunities.

Medtronic acquires Scientia Vascular for $550M to strengthen neurovascular offerings. Deal closes H1 FY2027, minimally dilutive in 2027, then accretive.

Global IV infusion pump market projected to grow from $6.72B in 2025 to $14.02B by 2035 at 7.6% CAGR, driven by aging populations and smart pump technology.

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.

Medtronic announces $0.71 quarterly dividend for Q4 FY2026, maintaining 48-year streak of consecutive annual increases and S&P 500 Dividend Aristocrats status.

BMY and MDT offer attractive dividend yields and growth potential, with BMY at 4% yield and MDT boasting 48 years of consecutive increases.

Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.

Royal Philips coordinates seven clinical trials across Europe to validate AI-assisted robotics for brain and liver tumor treatments, addressing physician shortages.

Global neurorehabilitation market projected to grow from $2.46B in 2025 to $6.96B by 2035, driven by rising neurological disorders and technological advances.

Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.

Medtronic gains FDA approval for Hugo robotic surgery system and spins off diabetes division, strengthening market position while reporting 8.7% revenue growth and maintaining 48-year dividend streak.

Medical device cleaning market projected to nearly double to $3.74B by 2032, driven by stricter infection control regulations and shift toward reusable devices in healthcare.

Anteris secures $320M funding to advance DurAVR heart valve through global trials, with FDA approval and increased clinical development spending.

Neuromodulation device market expected to double to $16.1 billion by 2032, driven by rising neurological diseases, technological advances, and regulatory support.

Brain-computer interface market projected to grow from $3.07B to $13.32B by 2035, driven by technological advances and neurological disorder prevalence.

Medtronic offers defensive stability through 48 years of dividend increases, essential medical devices, and consistent profitability across economic cycles.